FDA Announces 3 Final Guidances to Increase Patient Participation in Oncology Trials
Jul 28, 2026
View online
FDA Announces 3 Final Guidances to Increase Patient Participation in Oncology Trials
BCG Plus Immunotherapy Shows Modest Recurrence Benefit but Higher Toxicity in BCG-Naïve High-Risk NMIBC
Wafik El-Deiry: Scientific Freedom and Diverse Thinking Drive Better Medicine
Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring
Could Targeting MEK Help T Cells Fight Cancer for Longer?
10 Must-Read Posts In Radiotherapy This Week: July 20-26
Why Do Millions of Cancer Patients Still Lack Access to Radiotherapy? – CancerWorld
2027 Conquer Cancer Investigator Award in Drug Development
Conquer Cancer International Innovation Grant 2027
OPN New Jersey – New York Chapter Conference 2026
Asia-Pacific Gastroenterology Cancer Summit (APGCS 2026)
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
